CRA
Full-timeMidClinical Operation DeptOncologyUnknownBachelors
$10/yr
Description
Major Responsibilities and Duties
01. Ensure all business is conducted professionally in compliance with company policies and procedures.
02. Maintains working knowledge of protocols and Monitoring Plans for assigned projects.
03. Responsible for leading the EC submission team for GCP office pre-review and EC submission to meet start up timeline.
04. Verifies that the investigator, staff, and site facilities remain adequate throughout the trial period;
05. Responsible for scheduling and conducting of pre-study visits, initiation visits, interim monitoring visits and close-out visits according to the Monitoring Plan.
06. Ensures assigned sites are conducting studies according to protocol requirements.
07. Reconciles site regulatory binder assuring collection and completeness of regulatory documents.
08. Collects and ensures completeness of all essential regulatory documentation from sites from study start-up through close-out.
09. Verifies that written informed consent was obtained before each subject’s participation in the trial;
10. Verifies that the investigator is enrolling only eligible subjects.
11. Performs verification of source document s against Case Report Form/Electronic Data Capture entries to assure accurate and complete data. Ensures that any corrections are appropriately documented by authorized site staff.
12. Issues and ensures timely resolution of all data queries.
Requirements
1. Bachelor degree or above, Education with medical or pharmacy background.
2. More than 1 year CRA working experience on oncology study will be preferred.
3. Good written and verbal communications skills both in Chinese and English.
4. Good computer skills.
5. Self-motivated, have team-spirit, can work under pressure.
6. Ability to travel as required.
InxMed
BIOTECHNOLOGY
Oncology Treatments
LocationChina - Beijing
Employees1-50
Open Jobs4
Oncology
View Company ProfilePipeline
IN10018Phase 1
IN10018Phase 1
IN10018+PLDPhase 1/2
IN10018Phase 1/2
IN10018Phase 1/2